241 related articles for article (PubMed ID: 32677996)
1. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy.
Ding Y; Yao B; Hang H; Ye H
BMC Ophthalmol; 2020 Jul; 20(1):292. PubMed ID: 32677996
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage.
Yilmaz U; Akçaoğlu T; Avunduk MA; Kaya H; Parça O
Medicine (Baltimore); 2024 Jan; 103(3):e36963. PubMed ID: 38241585
[TBL] [Abstract][Full Text] [Related]
4. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
Lee DY; Jeong HS; Sohn HJ; Nam DH
Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
[TBL] [Abstract][Full Text] [Related]
6. Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.
Yokota R; Inoue M; Itoh Y; Rii T; Hirota K; Hirakata A
Jpn J Ophthalmol; 2015 Sep; 59(5):288-94. PubMed ID: 26202442
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
8. Soloist performance of vitrectomy probe in proliferative diabetic retinopathy.
Elwan MM; Hagras SM; Kasem MA
Eur J Ophthalmol; 2019 Mar; 29(2):251-256. PubMed ID: 29972027
[TBL] [Abstract][Full Text] [Related]
9. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Sameshima S; Ueda T; Ogata N; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Acta Ophthalmol; 2020 Jun; 98(4):e434-e439. PubMed ID: 31674137
[TBL] [Abstract][Full Text] [Related]
11. 23G Minimally Invasive Vitrectomy Combined with Glaucoma Drainage Valve Implantation and Phacoemulsification Cataract Extraction for Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Shi X; Dong N; Liang Y; Zheng L; Wang X
Comput Math Methods Med; 2022; 2022():7393661. PubMed ID: 35966245
[TBL] [Abstract][Full Text] [Related]
12. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
[TBL] [Abstract][Full Text] [Related]
13. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
14. 23-gauge versus 25-gauge vitrectomy for proliferative diabetic retinopathy: a comparison of surgical outcomes.
Guthrie G; Magill H; Steel DH
Ophthalmologica; 2015; 233(2):104-11. PubMed ID: 25471620
[TBL] [Abstract][Full Text] [Related]
15. Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.
Cheema RA; Mushtaq J; Cheema MA
Int Ophthalmol; 2010 Apr; 30(2):137-42. PubMed ID: 19169862
[TBL] [Abstract][Full Text] [Related]
16. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
[TBL] [Abstract][Full Text] [Related]
17. Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.
Wang Q; Zhao J; Xu Q; Han C; Hou B; Huang Y
BMC Ophthalmol; 2021 Mar; 21(1):129. PubMed ID: 33750339
[TBL] [Abstract][Full Text] [Related]
18. Vitreous rebleed following sutureless vitrectomy: Incidence and risk factors.
Mahalingam P; Topiwalla TT; Ganesan G
Indian J Ophthalmol; 2018 Apr; 66(4):558-561. PubMed ID: 29582819
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Yeh PT; Yang CH; Yang CM
Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
[TBL] [Abstract][Full Text] [Related]
20. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
